In many cases, the answer is yes
Semaglutide, marketed under the brand name Ozempic, has been used as a diabetes drug for over five years now
doi: 10.3389/fphar.2024.1414268 Received 08 April 2024 Accepted 13 May 2024 Published 03 June 2024 Volume 15 - 2024 Edited by Sheyu Li, Sichuan University, China Reviewed by Yiyuan Gao, Sichuan University, China Heyue Du, TidalHealth Neurosurgery, United States Erin St
The odds ratio was slightly above , but it was not conclusive. Based on these findings, the researchers concluded that GLP-1 receptor agonists could be used as a safe adjunctive therapy for smoking therapy by mitigating the weight gain that typically comes with quitting, particularly for patients who are more prone to relapse or otherwise vulnerable
Gastrointestinal-renal axis: role in the regulation of blood pressure